ペットがん治療薬の世界市場レポート 2024年

ペットがん治療薬の市場規模は近年急速に拡大しています。2023年の3億5,000万米ドルから2024年には3億9,000万米ドルに、CAGR11.8％で成長します。過去の期間に観察された成長は、ペット飼育の増加、獣医学の進歩、ペットの健康に対する意識の高まり、ペットの人間化、獣医サービスの拡大など、いくつかの要因に起因しています。これらの要因が相まって、ペットの健康と福祉への関心が高まり、ペットがん治療薬を含むペットヘルスケア産業の成長につながった。

ペットがん治療薬の市場規模は今後数年で急成長が見込まれます。2028年にはCAGR10.6％で5億9,000万米ドルに成長します。予測期間中に予想される成長は、ペットの高齢化の進展、ペットのがん治療の進歩、獣医腫瘍学サービスの台頭、ペット保険やヘルスケアプランの導入拡大、ペットケアサービスの世界的拡大などの要因によるものと考えられます。予測期間中に予想される主な動向には、ペットのがん治療のための栄養補助食品や統合療法の増加、標的診断検査の利用可能性の増加、分野横断的な洞察のための獣医腫瘍学とヒト腫瘍学の連携、ペット用に調整された新規の化学療法剤のイントロダクション、ペットのがんや利用可能な治療オプションに関する飼い主への教育の増加による意識の高まりなどがあります。

ペットヘルスケア支出の増加が予想されることから、ペットがん治療薬市場の拡大が見込まれます。ペットのヘルスケア支出には、獣医療サービス、医薬品、その他ペットのヘルスケア関連費用に充てられる資金が含まれます。ペットの健康に投資しようという飼い主の動向の高まりが、ペットヘルスケアへの支出増に反映され、ペットがん治療薬の需要増につながっています。例えば、North American Pet Health Insurance Association（NAPHIA）の2023 State of the Industry Reportでは、2022年末までに米国で保険に加入するペットの総数が2021年比で22％増加し、480万匹に達することが明らかにされています。このペットヘルスケア支出の急増がペットがん治療薬市場の原動力となっています。

ペットがん治療薬市場の成長は、ペットがんの有病率の増加によって推進されると予想されます。ペットがんは、家畜の異常で制御不能な細胞増殖を伴い、腫瘍形成につながります。ペットがんの罹患率の増加は、環境毒素、汚染物質、遺伝的およびライフスタイル要因に起因しています。その結果、ペット用の高度で効果的ながん治療薬に対する需要が高まっています。獣医がん協会（VCS）の2022年予測によると、犬の約4匹に1匹が一生の間にがんと診断され、高齢のペットではがんが主な死因となっています。また、米国国立がん研究所は、ペットの新たながん患者は年間約600万人と予測しており、今後数年で増加すると予測しています。ペットのがん罹患率の増加は、ペットがん治療薬市場の成長を牽引するものと考えられます。

2023年のペットがん治療薬市場で最大の地域は北米でした。ペットがん治療薬市場レポートの対象地域は、アジア太平洋,西欧,東欧,北米,南米,中東,アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 ペットがん治療薬市場の特徴

第3章 ペットがん治療薬市場の動向と戦略

第4章 ペットがん治療薬市場- マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界のペットがん治療薬市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 ペットがん治療薬市場セグメンテーション

• 世界のペットがん治療薬市場、がんタイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 黒色腫
• 肥満細胞がん
• リンパ腫
• 乳腺がんおよび扁平上皮がん
• 世界のペットがん治療薬市場、種族別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 犬
• 猫
• その他
• 世界のペットがん治療薬市場、治療別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 化学療法
• 放射線治療
• 免疫療法
• トモセラピー
• その他
• 世界のペットがん治療薬市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 動物病院
• 臨床薬局
• 小売薬局
• オンライン薬局
• その他

第7章 ペットがん治療薬市場の地域および国分析

• 世界のペットがん治療薬市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界のペットがん治療薬市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋のペットがん治療薬市場

第9章 中国のペットがん治療薬市場

第10章 インドのペットがん治療薬市場

第11章 日本のペットがん治療薬市場

第12章 オーストラリアのペットがん治療薬市場

第13章 インドネシアのペットがん治療薬市場

第14章 韓国のペットがん治療薬市場

第15章 西欧のペットがん治療薬市場

第16章 英国のペットがん治療薬市場

第17章 ドイツのペットがん治療薬市場

第18章 フランスのペットがん治療薬市場

第19章 イタリアのペットがん治療薬市場

第20章 スペインのペットがん治療薬市場

第21章 東欧のペットがん治療薬市場

第22章 ロシアのペットがん治療薬市場

第23章 北米のペットがん治療薬市場

第24章 米国のペットがん治療薬市場

第25章 カナダのペットがん治療薬市場

第26章 南米のペットがん治療薬市場

第27章 ブラジルのペットがん治療薬市場

第28章 中東のペットがん治療薬市場

第29章 アフリカのペットがん治療薬市場

第30章 ペットがん治療薬市場の競合情勢と企業プロファイル

• ペットがん治療薬市場の競合情勢
• ペットがん治療薬市場の企業プロファイル
  • AB Science
  • Boehringer Ingelheim GmbH
  • Elanco Animal Health
  • ELIAS Animal Health
  • Zoetis Inc.

第31章 世界のペットがん治療薬市場の競合ベンチマーキング

第32章 世界のペットがん治療薬市場の競争ダッシュボード

第33章 ペットがん治療薬市場における主要な合併と買収

第34章 ペットがん治療薬市場の将来展望と可能性分析

第35章 付録

“Pet Cancer Therapeutics Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pet cancer therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pet cancer therapeutics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The pet cancer therapeutics market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Cancer Type: Melanoma; Mast Cell Cancer; Lymphoma; Mammary And Squamous Cell Cancer
• 2) By Species: Dogs; Cats; Other Species
• 3) By Therapy: Chemotherapy; Radiation Therapy; Immunotherapy; TomoTherapy; Other Therapies
• 4) By End User: Veterinary Hospitals; Clinical Pharmacies; Retail Pharmacies; Online Pharmacies; Other End Users
• Companies Mentioned: AB Science; Boehringer Ingelheim GmbH; Elanco Animal Health; ELIAS Animal Health; Zoetis Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Pet cancer therapeutics involve the use of various treatments and medications to manage or cure cancer in pets. The choice of therapeutics depends on several factors such as the type and stage of cancer, as well as the pet's age and overall health.

The main types of pet cancer therapeutics are tailored to specific cancer types, including melanoma, mast cell cancer, lymphoma, and mammary and squamous cell cancer. Melanoma is a type of cancer that originates from pigment-producing cells called melanocytes. These therapeutics can be administered through various routes, including oral and injection methods, tailored for dogs, cats, and other animals. Different therapies employed in pet cancer treatment include chemotherapy, radiation therapy, immunotherapy, tomo therapy, and others. These therapies are utilized by veterinary hospitals, clinical pharmacies, retail pharmacies, online pharmacies, and other healthcare facilities focused on pet health.

The pet cancer therapeutics market research report is one of a series of new reports from The Business Research Company that provides pet cancer therapeutics market statistics, including pet cancer therapeutics industry global market size, regional shares, competitors with a pet cancer therapeutics market share, detailed pet cancer therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the pet cancer therapeutics industry. This pet cancer therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pet cancer therapeutics market size has grown rapidly in recent years. It will grow from $0.35 billion in 2023 to $0.39 billion in 2024 at a compound annual growth rate (CAGR) of 11.8%. The growth observed in the historical period can be attributed to several factors, including the rise in pet ownership, advancements in veterinary medicine, increased awareness of pet health, the humanization of pets, and the expansion of veterinary services. These factors collectively contributed to an increased focus on the health and well-being of pets, leading to growth in the pet healthcare industry, including pet cancer therapeutics.

The pet cancer therapeutics market size is expected to see rapid growth in the next few years. It will grow to $0.59 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%. The anticipated growth in the forecast period can be attributed to factors such as the growing aging pet population, advancements in cancer treatment for pets, the rise of veterinary oncology services, increased adoption of pet insurance and healthcare plans, and the global expansion of pet care services. Major trends expected in the forecast period include a rise in nutraceuticals and integrative therapies for pet cancer treatment, increased availability of targeted diagnostic tests, collaboration between veterinary and human oncology for cross-disciplinary insights, the introduction of novel chemotherapeutic agents tailored for pets, and a growing awareness with increased education for pet owners about cancer in pets and available treatment options.

The anticipated growth in pet healthcare expenditure is set to drive the expansion of the pet cancer therapeutics market. Pet healthcare expenditure encompasses the funds allocated for veterinary services, medications, and other healthcare-related costs for pets. The rising trend of pet owners' willingness to invest in their pets' well-being is reflected in the increased expenditure on pet healthcare, leading to a higher demand for pet cancer therapeutics. For example, the North American Pet Health Insurance Association's (NAPHIA) 2023 State of the Industry Report revealed a 22% increase in the total number of insured pets in the U.S. by the end of 2022, reaching 4.8 million, compared to 2021. This surge in pet healthcare expenditure is a driving force for the pet cancer therapeutics market.

The growth of the pet cancer therapeutics market is expected to be propelled by the increasing prevalence of pet cancer. Pet cancer involves abnormal and uncontrolled cell growth in domesticated animals, leading to tumor formation. The rising incidence of pet cancer is attributed to environmental toxins, pollutants, and genetic and lifestyle factors. Consequently, there is an escalating demand for advanced and effective cancer therapeutics for pets. According to the Veterinary Cancer Society's (VCS) 2022 predictions, approximately 1 in 4 dogs is diagnosed with cancer during their lifetime, with cancer being a primary cause of death among older pets. Additionally, the National Cancer Institute anticipates approximately 6 million new cancer cases in pets annually, with a projected increase in the coming years. The increasing prevalence of pet cancer is poised to drive the growth of the pet cancer therapeutics market.

Technological advancement emerges as a prominent trend gaining popularity in the pet cancer therapeutics market. Major players are dedicating efforts to develop innovative technologies to enhance their market position. For instance, in May 2021, PetDx, a U.S.-based biotech company in the animal health industry, introduced OncoK9, a cutting-edge blood-based multi-cancer early detection (MCED) test designed specifically for dogs. This technology employs advanced genomic analysis, leveraging next-generation sequencing (NGS) to provide enhanced capabilities for cancer detection.

Strategic partnerships are a significant approach adopted by major companies in the pet cancer therapeutics market to achieve superior disease control. This collaborative strategy involves leveraging each other's strengths and resources to attain mutual benefits and success. One such collaboration occurred in June 2022, when Germany-based pharmaceutical company Boehringer Ingelheim partnered with U.S.-based biopharmaceutical company CarthroniX. The collaboration focuses on identifying new small molecules to target cancers in dogs, potentially offering superior disease control. CarthroniX will supply the small molecules for evaluation by Boehringer Ingelheim, emphasizing their commitment to advancing oncology research in animal health and exploring new therapeutic options for the treatment of canine cancer.

In June 2021, Elanco, a U.S.-based animal health company, acquired Kindred Biosciences for an undisclosed amount. This strategic acquisition positions Elanco to expand its portfolio of animal health products and gain access to new technologies and development platforms. Kindred Biosciences, a U.S.-based biopharmaceutical company, specializes in developing innovative treatments for pets.

Major companies operating in the pet cancer therapeutics market report are AB Science, Boehringer Ingelheim GmbH, Elanco Animal Health, ELIAS Animal Health, Zoetis Inc., Aratana Therapeutics Inc., Anivive Lifesciences Inc., QBiotics Group Ltd., Regeneus Ltd., VetDC Inc., PetCure Oncology at Veterinary Radiosurgery and Imaging Center, Karyopharm Therapeutics Inc., Torigen Pharmaceuticals Inc., virology and bacteriology, Nippon Zenyaku Kogyo Co. Ltd., Vivesto AB, Dechra Pharmaceuticals plc, Elekta Medical Systems India Pvt. Ltd., Norbrook Laboratories Ltd., AdvaVet Inc., Merial Animal Health Ltd., Oasmia Pharmaceuticals AB, Zenoaq Co. Ltd., Rhizen Pharmaceuticals SA, Morphogenesis Inc., Pfizer Inc., Sumitomo Pharma Animal Health Co., Vetivax, CarthroniX Inc

North America was the largest region in the pet cancer therapeutics market in 2023. The regions covered in the pet cancer therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pet cancer therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pet cancer therapeutics market consists of revenues earned by entities by surgery and palliative care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Pet Cancer Therapeutics Market Characteristics

3. Pet Cancer Therapeutics Market Trends And Strategies

4. Pet Cancer Therapeutics Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Pet Cancer Therapeutics Market Size and Growth

• 5.1. Global Pet Cancer Therapeutics Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Pet Cancer Therapeutics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Pet Cancer Therapeutics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pet Cancer Therapeutics Market Segmentation

• 6.1. Global Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Melanoma
• Mast Cell Cancer
• Lymphoma
• Mammary And Squamous Cell Cancer
• 6.2. Global Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Dogs
• Cats
• Other Species
• 6.3. Global Pet Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Chemotherapy
• Radiation Therapy
• Immunotherapy
• TomoTherapy
• Other Therapies
• 6.4. Global Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Veterinary Hospitals
• Clinical Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Other End Users

7. Pet Cancer Therapeutics Market Regional And Country Analysis

• 7.1. Global Pet Cancer Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Pet Cancer Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pet Cancer Therapeutics Market

• 8.1. Asia-Pacific Pet Cancer Therapeutics Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pet Cancer Therapeutics Market

• 9.1. China Pet Cancer Therapeutics Market Overview
• 9.2. China Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pet Cancer Therapeutics Market

• 10.1. India Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pet Cancer Therapeutics Market

• 11.1. Japan Pet Cancer Therapeutics Market Overview
• 11.2. Japan Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pet Cancer Therapeutics Market

• 12.1. Australia Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pet Cancer Therapeutics Market

• 13.1. Indonesia Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pet Cancer Therapeutics Market

• 14.1. South Korea Pet Cancer Therapeutics Market Overview
• 14.2. South Korea Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pet Cancer Therapeutics Market

• 15.1. Western Europe Pet Cancer Therapeutics Market Overview
• 15.2. Western Europe Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pet Cancer Therapeutics Market

• 16.1. UK Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pet Cancer Therapeutics Market

• 17.1. Germany Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pet Cancer Therapeutics Market

• 18.1. France Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pet Cancer Therapeutics Market

• 19.1. Italy Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pet Cancer Therapeutics Market

• 20.1. Spain Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pet Cancer Therapeutics Market

• 21.1. Eastern Europe Pet Cancer Therapeutics Market Overview
• 21.2. Eastern Europe Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pet Cancer Therapeutics Market

• 22.1. Russia Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pet Cancer Therapeutics Market

• 23.1. North America Pet Cancer Therapeutics Market Overview
• 23.2. North America Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pet Cancer Therapeutics Market

• 24.1. USA Pet Cancer Therapeutics Market Overview
• 24.2. USA Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pet Cancer Therapeutics Market

• 25.1. Canada Pet Cancer Therapeutics Market Overview
• 25.2. Canada Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pet Cancer Therapeutics Market

• 26.1. South America Pet Cancer Therapeutics Market Overview
• 26.2. South America Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pet Cancer Therapeutics Market

• 27.1. Brazil Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pet Cancer Therapeutics Market

• 28.1. Middle East Pet Cancer Therapeutics Market Overview
• 28.2. Middle East Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pet Cancer Therapeutics Market

• 29.1. Africa Pet Cancer Therapeutics Market Overview
• 29.2. Africa Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pet Cancer Therapeutics Market Competitive Landscape And Company Profiles

• 30.1. Pet Cancer Therapeutics Market Competitive Landscape
• 30.2. Pet Cancer Therapeutics Market Company Profiles
  • 30.2.1. AB Science
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Boehringer Ingelheim GmbH
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Elanco Animal Health
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. ELIAS Animal Health
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Zoetis Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Pet Cancer Therapeutics Market Competitive Benchmarking

32. Global Pet Cancer Therapeutics Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Pet Cancer Therapeutics Market

34. Pet Cancer Therapeutics Market Future Outlook and Potential Analysis

• 34.1 Pet Cancer Therapeutics Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Pet Cancer Therapeutics Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Pet Cancer Therapeutics Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer